Skip to main content
TipRanks
Go Ultimate75% OFF

David Gionco Insider Profile

4 Followers

David Gionco, former CAO at Stemline Therapeutics, holds 0.00 shares in Stemline Therapeutics (Ticker: STML), holds 53.49K shares in Savient Pharmaceuticals (Ticker: SVNTQ).

David Gionco's Trading History

STML
Stemline Therapeutics
Jun 10, 2020―Uninformative Buy―$0.00
SVNTQ
Savient Pharmaceuticals
Jul 25, 2012―Uninformative Buy――

You May Also Like

David Gionco insider profile FAQ

What is the percentage of profitable transactions made by David Gionco?
The percentage of profitable transactions made by David Gionco is 62%.
What is the average return per transaction made by David Gionco?
The average return per transaction made by David Gionco is -9.20%.
What stocks does David Gionco hold?
David Gionco holds: STML, SVNTQ stocks.
What was David Gionco's most profitable transaction?
David Gionco’s most profitable transaction was an Informative Sell of STML stock on March 15, 2019. The return on the trade was 66.70%.
What is David Gionco's role in Stemline Therapeutics?
David Gionco's role in Stemline Therapeutics is CAO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.